Alternative digestion strategy for Ti, Zr and Hf oxides: eliminating hydrofluoric acid


Loading...

Date

2025-07-14

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

Group IV metal oxides have a broad impact on the environment and human health due to their diverse applications in industry, consumer products and biomedicine. However, their chemical inertness poses significant challenges for accurate quantification in biological matrices, which is essential for assessing biodistribution, toxicity, and regulatory compliance. Traditional digestion methods often rely on hydrofluoric acid (HF), a hazardous reagent requiring specialized handling and infrastructure. Here, we present an alternative, HF-free microwave assisted digestion protocol for group IV metal oxides in biological contexts, utilizing sulfuric acid/water/hydrogen peroxide mixtures to achieve complete solubilization across nano-to microscale particles. The method's efficacy was evaluated on various commercially available TiO2, ZrO2, and HfO2 powders. Optimization of digestion parameters, including acid-to-peroxide ratios, temperature, and reaction time, led to recoveries exceeding 90% for all tested materials. Notably, higher temperatures and extended digestion times were required for larger particles and higher atomic number oxides, reflecting the increased metal-oxygen bond dissociation energies. The method's applicability was further demonstrated through successful quantification of spiked nanoparticles in human cancer cells and bovine liver tissue, with detection limits down to similar to 1 ppb and achieving recoveries within 80-100%, maintaining sample stability over four weeks. Comparative analysis with HF-based digestion revealed comparable sensitivity and detection limits using inductively coupled plasma optical emission spectrometry (ICP-OES), with the HF-free method offering a safer and more accessible alternative for routine laboratory analysis. This validated protocol facilitates accurate quantification of group IV metal oxides in complex biological matrices, supporting preclinical and clinical studies while mitigating the risks associated with HF usage.

Publication status

published

Editor

Book title

Volume

17 (26)

Pages / Article No.

5334 - 5342

Publisher

Royal Society of Chemistry

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

Organisational unit

Notes

Funding

Related publications and datasets